Introduction to Non Influenza Respiratory

What is/are Non Influenza Respiratory?

Non Influenza Respiratory - In addition, we studied the potential interference between SIV and ILI caused by non-influenza respiratory viruses (NIRV) based on data collated from 2017/18 to 2019/20 seasons. ^[1] Increasing evidence indicates that non-influenza respiratory viruses (NIRV) also contribute to the burden of SARI. ^[2] Increasing evidence indicates that non-influenza respiratory viruses (NIRVs) also contribute to the burden of SARI. ^[3] Conclusions Patients infected with SARS-CoV-2 along with a non-influenza respiratory virus had less severe disease on presentation and were more likely to be admitted—but did not have more severe outcomes—than those infected with SARS-CoV-2 alone. ^[4] The authors come to the curious conclusion that patients infected with SARS-CoV-2 along with a non-influenza respiratory virus had less-severe disease on presentation and did not have more severe outcomes than those infected with SARS-CoV-2 alone. ^[5] CONCLUSIONS Influenza vaccination coverage over eight seasons among outpatients with non-influenza respiratory illness was slightly higher than coverage in the general population but 15% lower than national targets. ^[6] Background Although influenza vaccines provide protection against influenza viruses, concern has been raised that they may increase susceptibility to non-influenza respiratory viruses. ^[7] OBJECTIVE We evaluated the incidence of influenza and non-influenza respiratory viruses (NIRVs) pre-/post-implementation of public health (PH) measures aimed to decrease COVID-19 transmission using population-based surveillance data. ^[8] Although broad knowledge of influenza viral pneumonia has been established, the significance of non-influenza respiratory viruses in community-acquired pneumonia (CAP) and their impact on clinical outcomes remains unclear, especially in the non-immunocompromised adult population. ^[9] Transmission of non-influenza respiratory viruses in households can inform preventative interventions and has not been well-characterised in South Asia. ^[10] All samples were tested for RSV A and B using real-time polymerase chain reaction for non-influenza respiratory viruses. ^[11] Conclusions Non-influenza respiratory microorganisms frequently co-circulated during the epidemic peaks of influenza, which easily being ignored in CAP therapy. ^[12] Respondents were asked to (1) rate daily workload increase as 60 minutes in response to five exposure (lice/scabies, mumps/measles, pertussis, tuberculosis, influenza) and outbreak scenarios (methicillin-resistant Staphylococcus aureus, other multidrug-resistant organisms, non-influenza respiratory viruses, Clostridium difficile, gastrointestinal viruses), and (2) rank most time consuming activities during exposure/outbreak responses. ^[13] CONCLUSIONS This study revealed that non-influenza respiratory viruses were a major contributor to ILI. ^[14] Patients with a non-influenza respiratory virus were less likely to experience severe clinical outcomes than patients with A/H1, however, had similar likelihood when compared to patients with A/H3. ^[15] Background The population-based incidence and burden of community-onset non-influenza respiratory viruses associated with hospitalization in adults has not been systematically assessed. ^[16]